Mandelboim, M., Mendelson, E., Drori, Y., Atari, N., Lapidot, T., Megiddo, D., & Gladnikoff, M. (2021). Taffix® Nasal Powder Spray Forms an Effective Barrier Against Infectious New Variants of SARS-Cov-2 (Alpha, Beta and Delta). Archives of Clinical and Biomedical Research, 5(5), 794–802. Retrieved from https://fortunejournals.org/ojs/index.php/acbr/article/view/14869